These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12148385)

  • 21. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
    Petitpretz P; Choné C; Trémolières F;
    Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute exacerbations of chronic bronchitis: a pharmacoeconomic review of antibacterial use.
    Morris S; Anderson P; Irwin DE
    Pharmacoeconomics; 2002; 20(3):153-68. PubMed ID: 11929346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
    Destache CJ; Dewan N; O'Donohue WJ; Campbell JC; Angelillo VA
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():107-13. PubMed ID: 10225580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
    [No Abstract]   [Full Text] [Related]  

  • 25. [Levofloxacin and macrolides in chronic bronchitis exacerbation: comparative analysis of the treatment efficacy and nonrelapsing periods].
    Dvoretskiĭ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Sidorenko SV; Iakovlev SV
    Antibiot Khimioter; 2007; 52(7-8):21-31. PubMed ID: 18986021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
    Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
    Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients.
    Lorenz J; Busch W; Thate-Waschke IM;
    J Int Med Res; 2001; 29(2):61-73. PubMed ID: 11393350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparative study of ofloxacin (Hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease.
    Boye NP; Gaustad P
    Infection; 1991; 19 Suppl 7():S388-90. PubMed ID: 1804789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Levofloxacin in the treatment of respiratory infections].
    Iakovlev SV; Iakovlev VP
    Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral ofloxacin once daily and doxycycline in the treatment of acute exacerbations of chronic bronchitis.
    Punakivi L; Keistinen T; Backman R; Lehtipuu AL; Saarelainen P; Vilkka V; Veneskoski T; Ammälä K; Aro A
    Scand J Infect Dis Suppl; 1990; 68():41-5. PubMed ID: 2218421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sparfloxacin and levofloxacin.
    Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295
    [No Abstract]   [Full Text] [Related]  

  • 33. New insights in the treatment by levofloxacin.
    File TM
    Chemotherapy; 2004; 50 Suppl 1():22-8. PubMed ID: 15319551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of recovery of health status following an infective exacerbation of chronic bronchitis.
    Spencer S; Jones PW;
    Thorax; 2003 Jul; 58(7):589-93. PubMed ID: 12832673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fluoroquinolone-induced Achilles tendon rupture].
    Maurin N
    Dtsch Med Wochenschr; 2008 Feb; 133(6):241-4. PubMed ID: 18236349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Cantón R; Lode H; Graninger W; Milkovich G
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.
    Nouira S; Marghli S; Belghith M; Besbes L; Elatrous S; Abroug F
    Lancet; 2001 Dec; 358(9298):2020-5. PubMed ID: 11755608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of ofloxacin and pivmecillinam in acute exacerbations of chronic bronchitis.
    Egede F; Kristensen I
    Scand J Infect Dis Suppl; 1990; 68():46-9. PubMed ID: 2218422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic and bronchodilator prescribing for acute bronchitis in the emergency department.
    Kroening-Roche JC; Soroudi A; Castillo EM; Vilke GM
    J Emerg Med; 2012 Aug; 43(2):221-7. PubMed ID: 22341759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.